New study identifies dopamine's role in reversing Alzheimer's

Imagine if patients with Alzheimer's could have their memories restored. Such a future may seem like a pipe dream, but a new study by researchers at Tohoku University, in collaboration with the University of California, Irvine, has identified dopamine dysfunction as a previously unrecognized mechanism underlying memory impairment, unlocking a potential therapeutic means of reversing cognitive decline.

Whether a certain smell brings you back to a place from your youth or a song on the radio makes you recall an event from the past, memory formation is often associated with experiences. While scientists have long known that the medial temporal lobe lies at the heart of memory formation, they have struggled to understand the neural changes that disrupt this process in Alzheimer's disease.

To investigate this, a research team led by Kei Igarashi, a Distinguished Professor at Tohoku University School of Medicine, focused on the entorhinal cortex, a brain region that serves as a gateway to the hippocampus and is essential for memory processing. Building on previous findings that dopamine is critical for memory formation in this region, the team investigated whether dopamine dysfunction contributes to memory deficits associated with Alzheimer's disease.

Using a mouse model of Alzheimer's disease, the researchers found that dopamine levels in the entorhinal cortex were dramatically reduced to less than 20% of normal levels. This reduction was accompanied by severe impairments in associative memory, which were observed during odor-based learning tasks. Electrophysiological analyses further revealed that neurons in this region failed to respond appropriately to stimuli that should be encoded as memories.